Pilot and Feasibility Program
The program will support innovative new projects that explore the feasibility of novel, testable concepts and enhance the digestive and liver disease research scope following the themes of the center. The program specifically supports junior faculty, faculty new to digestive and liver disease research, women and underrepresented minorities engaged in cross-disciplinary research.
The P&F pilot feasibility project recipients will have priority to use CSDDRC research core services.
Established investigators working in research related to GI, liver and pancreatic disease who wish to start a new project representing a major departure from their previous NIH or other federally funded research. New collaborative research between a CSDDRC investigator and a non-CSDDRC investigator would be eligible under this category.
Eligibility
All academic full-time faculty—including instructors, faculty research scientists and assistant professors—who are eligible to apply as a principal investigator for extramural National Institutes of Health (NIH) R01 funding and who are affiliated with Cedars-Sinai Medical Center are eligible to apply for a Cedars-Sinai Digestive Diseases Research Center (CSDDRC) Pilot and Feasibility Program grant. Applicants may fall into any of the following three categories based on NIH guidelines:
New investigators (as defined by NIH guidelines) without independent extramural grant support (including federal, R01, R00, U01, P01, DoD, VA merit or equivalent, and excluding career-development awards, such as K, AGA, AASLD, ALF, and Crohn's and Colitis Foundation of America) who seek to establish independence in the field of gastrointestinal (GI), liver and pancreatic disease research.
Established investigators with independent grant support—past or present—who wish to develop a new research direction related to GI, liver and pancreatic disease research.
Established investigators working in research related to GI, liver and pancreatic disease who wish to start a new project representing a major departure from their previous NIH or other federally funded research. New collaborative research between a CSDDRC investigator and a non-CSDDRC investigator would be eligible under this category.
2022 Pilot Feasibility Grant Awardee
Principal Investigator
Ivan Vujkovic-Cvijin, PhD, Assistant Professor, Department of Biomedical Sciences and Medicine, Karsh Division of Gastroenterology and Hepatology
Title
Identifying immunostimulatory gut bacteria associated with disease progression in Crohn’s disease
Funded Budget
$25,000 for one year (July 1, 2022-June 30, 2023)
Eligibility
Category 1
Previous Pilot Feasibility Grant Awardee Outcomes
- 2021 P&F awardee Dr. Nirmala Mavila was awarded a new grant R01DK131071, titled: “FGFR Signaling in Liver Injury and Fibrosis”, starting July 2022.
Have Questions or Need Help?
If you have questions or would like to learn more about the CSDDRC, please contact Shelly Lu, MD, or Stephen Pandol, MD.
Davis Building, Room 2097
8700 Beverly Blvd.
Los Angeles, CA 90048